Drug trial for chronic hives withdrawn before starting
Disease control
Terminated
This study aimed to test if the drug ritlecitinib is safe and effective for treating chronic spontaneous urticaria (CSU), a condition causing long-lasting hives and itching. Eligible adults with CSU not well-controlled by standard antihistamines would have taken the oral drug dai…
Phase: PHASE2 • Sponsor: Ahuva D Cices • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC